Health & Biotech
Check out the latest Medical Cannabis news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts.
Health & Biotech
Incannex appoints experienced lead investigators for Phase-2/3 clinical trial into sleep apnoea
Health & Biotech
Bioxyne positions for growth following Breathe Life Sciences acquisition
Health & Biotech
First UK patients receive MGC Pharma’s CannEpil product
Health & Biotech
Incannex’s subsidiary to open multiple psychedelic clinics to capture wide open opportunity
Health & Biotech
Creso wraps up Health House acquisition, expands global cannabis footprint
Health & Biotech
Creso Pharma’s wholly-owned US subsidiary Sierra Sage Herbs expands into Canada
Health & Biotech
Creso Pharma subsidiary granted amended cannabis 2.0 licence in Canada
Health & Biotech
Creso welcomes news that US cannabis banking and expungements bill is close
Explainers
ASX Cannabis Stocks Guide 2022/23: Here’s everything you need to know
Health & Biotech
Creso ready to capitalise on potential US reclassification of cannabis
Investor Guides
Investor Guide: Health & Biotech FY2023
Health & Biotech
Creso Pharma’s acquisition target lands deal with leading US online health marketplace
Health & Biotech
Encouraging signs for MGC Pharma after cannabinoid treatment for aggressive brain cancer breakthrough
Health & Biotech
Creso Pharma shares surge ~12% after inking tattoo sector deal
Health & Biotech
Medlab Clinical set to export first CBD product into the UK market
Health & Biotech
Punching the lights out: Best half year ever for MGC Pharma as it triples revenue, aims to convert clinical trials to sales
Health & Biotech
Creso Pharma’s Halucenex gets green light for Phase 2 clinical trial of psilocybin for PTSD
Health & Biotech
Stock Insiders: Legendary Canadian cannabis entrepreneur Bruce Linton on the sector’s future and why he’s backing Creso Pharma
Health & Biotech
Creso Pharma stakes its claim of the multibillion US CBD market in landmark acquisition
Health & Biotech
With Boots on ground in UK, organic cannabis innovator Dragonfly has blue sky options ahead of ASX debut
Health & Biotech
What you’ve been vaping for: MGC Pharma now has the first-ever Cannabinoid vape available as an unapproved therapeutic good for use in Australia
Health & Biotech
Cannabis play Epsilon boosted by $2.9m fresh capital as it targets profit in 2022
Health & Biotech
Creso Pharma ready to move as Republicans ramp up legal cannabis push in US
Health & Biotech
Creso Pharma makes inroads in North America and enters the sports market for CBD after acquisition
Health & Biotech
Epsilon signs long-term manufacturing deal for Cannim’s Jamaican cannabis products
Health & Biotech
Creso Pharma makes further traction in Canada after receiving substantial orders for its cannabis products
Food & Agriculture
Roto-Gro receives first order from Canniberia LDA, secures foothold in growing Euro market
Health & Biotech
Epsilon clinches first cannabis orders from The Valens, sets eyes on the European markets
Health & Biotech
Here’s why this fundie expects MGC Pharma’s stock price to more than double
Health & Biotech
MGC Pharma makes inroads in the fight against COVID-19, getting a regulatory nod in Germany and a successful trial in India
Health & Biotech
MGC Pharma share price soars after CannEpil+ scores UK-first import deal
Health & Biotech
Creso Pharma expands European footprint with additional hemp seed oil purchase orders
Health & Biotech
Epsilon signs deal with Canadian cannabis products powerhouse The Valens Company
Health & Biotech
Creso Pharma and Red Light Holland call off merger, as NASDAQ beckons
Health & Biotech
Creso Pharma’s psychedelics subsidiary Halucenex receives Canadian licence approval, targets Phase II trials on PTSD
Health & Biotech
Creso Pharma’s Canadian subsidiary Mernova secures licence for medicinal cannabis in Canada
Health & Biotech
ECS Botanics jumps almost 5pc on $4.5 million Polish deal
Food & Agriculture
RotoGro nabs deposit from Wolf Island to supply tech for new cannabis cultivation facility
Health & Biotech
Cymra secures cultivation permit as it builds a first-mover advantage in cannabis genetics
Health & Biotech
Medibis raises funds for research and cultivation facility, sets eyes on huge medicinal cannabis market
Health & Biotech
Creso Pharma welcomes Senate Democrats’ bid to legalise cannabis
Health & Biotech
Creso Pharma completes acquisition of Canada-based Halucenex, set to enter the US$100 billion psychedelic market
Health & Biotech
Stock Insiders Podcast: Wellnex Life moving from strength to strength after rebrand and latest aquisition
Health & Biotech
Creso Pharma delivers another strong quarter as Connecticut brings a new market opportunity
Health & Biotech
Creso Pharma US shares surge on dual-listing
Health & Biotech
Creso Pharma’s takeover target expands scope of PTSD ‘shroom’ trial beyond military vets
Health & Biotech
Creso Pharma sells hemp products in Ecuador, gears up for the lucrative Latin American market
Load More
